Friday 22 September 2017

Biomnis to invest €3m in pathology

BIOMNIS, the medical-testing and specialised medical-pathology company, is to invest about €3m in the Irish pathology sector. The investment includes the acquisition of Euromedic Lablink, which will join forces with Claymon Biomnis to create Biomnis Ireland.

Starbucks brews up single-digit growth

COFFEE

THE Irish arm of Starbucks said last night that it had achieved "accelerated single-digit growth" during the third quarter. The coffee giant, which does not usually break out business performance by country, said the three months to the end of September marked the "second quarter of sales growth" since the beginning of the downturn.

Irish Life defeated in Dutch court case

INVESTMENT

IRISH Life Investment Managers has suffered a setback after a Dutch commercial court rejected its request for a probe into how European planemaker Airbus's parent communicated with shareholders. The case had been brought by Germany's Deka Investment and Irish Life Investment Managers.

Sales at Morrison boosted by 2.8pc

SUPERMARKETS

WILLIAM Morrison Supermarkets, the UK chain headed by former Brown Thomas boss Dalton Philips, said yesterday that its total sales, excluding fuel, in the third quarter rose 2.8pc, with like-for-like sales up 1.3pc higher.

S&P downgrades AIB's UK business

BANKS

RATINGS agency Standard & Poor's yesterday downgraded its outlook for AIB's British business to "negative", citing the group's difficulties in selling its UK offshoot.

Quinns-backed firm loses €3.7m

INVESTMENT

AN investment company backed by the family of Senator Feargal Quinn lost €3.7m last year. Claret Capital's reported the pre-tax loss in accounts filed for 2009. Losses were up from €3.4m in 2008. The company, established by financier Domhnal Slattery, is 25pc-owned by Mr Quinn's family.

Irish Independent

Also in Business